CCRN RSI Chart
Last 7 days
-2.2%
Last 30 days
-13.5%
Last 90 days
-16.8%
Trailing 12 Months
-42.3%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 1.8B | 0 | 0 | 0 |
2023 | 2.6B | 2.4B | 2.2B | 2.0B |
2022 | 2.1B | 2.6B | 2.8B | 2.8B |
2021 | 955.6M | 1.1B | 1.3B | 1.7B |
2020 | 837.1M | 851.1M | 835.9M | 836.4M |
2019 | 801.4M | 799.6M | 808.0M | 822.2M |
2018 | 867.8M | 863.0M | 835.3M | 816.5M |
2017 | 844.5M | 854.4M | 867.9M | 865.0M |
2016 | 778.0M | 784.9M | 804.2M | 833.5M |
2015 | 685.7M | 755.7M | 762.4M | 767.4M |
2014 | 446.1M | 458.0M | 538.9M | 617.8M |
2013 | 443.2M | 445.1M | 440.9M | 438.3M |
2012 | 442.8M | 442.1M | 439.9M | 442.6M |
2011 | 391.7M | 383.4M | 382.1M | 439.4M |
2010 | 0 | 521.0M | 463.8M | 406.6M |
2009 | 0 | 0 | 0 | 578.2M |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index
Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>
Returns of $10,000 invested in:
Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224
Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Mar 31, 2024 | noe phillip lyn | acquired | - | - | 5,502 | chief information officer |
Mar 31, 2024 | mcdonald colin patrick | acquired | - | - | 6,411 | chief human resources officer |
Mar 31, 2024 | noe phillip lyn | sold (taxes) | -53,052 | 18.72 | -2,834 | chief information officer |
Mar 31, 2024 | mote karen | acquired | - | - | 3,473 | pres., cross country locums |
Mar 31, 2024 | burns william j. | acquired | - | - | 22,036 | chief financial officer |
Mar 31, 2024 | ball susan e | acquired | - | - | 15,358 | general counsel and secretary |
Mar 31, 2024 | martins john anthony | sold (taxes) | -322,920 | 18.72 | -17,250 | president, ceo |
Mar 31, 2024 | mote karen | sold (taxes) | -67,148 | 18.72 | -3,587 | pres., cross country locums |
Mar 31, 2024 | white daniel joseph | sold (taxes) | -43,299 | 18.72 | -2,313 | former chf. commercial officer |
Mar 31, 2024 | grieco cynthia ann | sold (taxes) | -26,245 | 18.72 | -1,402 | vp, corporate treasurer |
Which funds bought or sold CCRN recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 16, 2024 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | reduced | -7.11 | -188,900 | 625,529 | -% |
May 16, 2024 | COMERICA BANK | added | 117 | 281,171 | 633,812 | -% |
May 16, 2024 | JANE STREET GROUP, LLC | sold off | -100 | -258,526 | - | -% |
May 15, 2024 | PARADIGM CAPITAL MANAGEMENT INC/NY | unchanged | - | -422,184 | 2,016,140 | 0.10% |
May 15, 2024 | Aquatic Capital Management LLC | new | - | 91,728 | 91,728 | -% |
May 15, 2024 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | reduced | -11.5 | -2,924,150 | 7,977,720 | 0.16% |
May 15, 2024 | Mariner, LLC | sold off | -100 | -2,847,070 | - | -% |
May 15, 2024 | Centiva Capital, LP | added | 80.26 | 205,574 | 624,686 | 0.01% |
May 15, 2024 | UBS ASSET MANAGEMENT AMERICAS LLC | unchanged | - | -248,844 | 1,188,340 | -% |
May 15, 2024 | MILLENNIUM MANAGEMENT LLC | new | - | 4,711,520 | 4,711,520 | -% |
Unveiling Cross Country Healthcare Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Cross Country Healthcare Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 482.9B | 379.5B | 31.44 | 1.27 | ||||
CI | 96.2B | 206.0B | 24.97 | 0.47 | ||||
HCA | 84.6B | 66.7B | 15.46 | 1.27 | ||||
CVS | 72.4B | 360.9B | 9.89 | 0.2 | ||||
CNC | 41.7B | 155.5B | 15.24 | 0.27 | ||||
DVA | 12.3B | 12.3B | 15.03 | 0.99 | ||||
UHS | 11.9B | 14.7B | 14.63 | 0.81 | ||||
MID-CAP | ||||||||
CHE | 8.5B | 2.3B | 30.15 | 3.73 | ||||
ACHC | 6.2B | 3.0B | -545.12 | 2.06 | ||||
AMEH | 2.3B | 1.5B | 36.62 | 1.57 | ||||
AMN | 2.2B | 3.5B | 15.49 | 0.64 | ||||
SMALL-CAP | ||||||||
ADUS | 1.8B | 1.1B | 27.59 | 1.67 | ||||
BKD | 1.3B | 3.0B | -7.66 | 0.44 | ||||
BEAT | 54.5M | - | -3.61 | - | ||||
AMS | 22.0M | 21.6M | 39.79 | 1.02 |
Cross Country Healthcare Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -8.4% | 379 | 414 | 442 | 541 | 623 | 628 | 636 | 754 | 789 | 641 | 375 | 332 | 329 | 216 | 194 | 217 | 210 | 215 | 209 | 203 | 195 |
Costs and Expenses | -6.1% | 376 | 401 | 422 | 506 | 579 | 577 | 584 | 675 | 698 | 565 | 348 | 316 | 308 | 210 | 194 | 230 | 211 | 213 | 209 | 218 | 198 |
S&GA Expenses | -6.4% | 63.00 | 68.00 | 70.00 | 79.00 | 84.00 | 81.00 | 81.00 | 86.00 | 77.00 | 67.00 | 53.00 | 50.00 | 46.00 | 45.00 | 41.00 | 42.00 | 46.00 | 46.00 | 44.00 | 46.00 | 46.00 |
EBITDA Margin | -21.4% | 0.05* | 0.06* | 0.07* | 0.08* | 0.09* | 0.10* | 0.11* | 0.11* | 0.10* | 0.09* | 0.06* | 0.05* | 0.03* | - | - | - | - | - | - | - | - |
Interest Expenses | -21.2% | 0.00 | 1.00 | 1.00 | 3.00 | 4.00 | 4.00 | 3.00 | 4.00 | 4.00 | 3.00 | 2.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Income Taxes | -74.6% | 1.00 | 4.00 | 7.00 | 9.00 | 11.00 | 8.00 | 14.00 | 21.00 | 25.00 | -4.27 | 1.00 | 3.00 | 1.00 | -0.16 | 0.00 | -0.38 | 0.00 | -0.11 | 0.00 | 35.00 | -3.01 |
Earnings Before Taxes | -71.6% | 4.00 | 13.00 | 20.00 | 30.00 | 40.00 | 46.00 | 49.00 | 74.00 | 87.00 | 73.00 | 25.00 | 15.00 | 20.00 | 5.00 | -0.98 | -14.43 | -1.59 | -0.71 | -2.60 | -16.51 | -4.39 |
EBT Margin | -26.5% | 0.04* | 0.05* | 0.06* | 0.07* | 0.08* | 0.09* | 0.10* | 0.10* | 0.09* | 0.08* | 0.05* | 0.04* | 0.01* | - | - | - | - | - | - | - | - |
Net Income | -70.2% | 3.00 | 9.00 | 13.00 | 21.00 | 29.00 | 39.00 | 35.00 | 53.00 | 62.00 | 78.00 | 23.00 | 12.00 | 19.00 | 5.00 | -1.33 | -14.15 | -2.09 | -1.14 | -3.13 | -51.67 | -1.77 |
Net Income Margin | -28.2% | 0.03* | 0.04* | 0.05* | 0.05* | 0.06* | 0.07* | 0.08* | 0.08* | 0.08* | 0.08* | 0.05* | 0.03* | 0.01* | - | - | - | - | - | - | - | - |
Free Cashflow | -58.7% | 4.00 | 9.00 | 67.00 | 115 | 43.00 | 2.00 | 138 | 16.00 | -31.13 | -75.64 | -4.72 | 14.00 | -26.11 | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | -4.5% | 648 | 679 | 708 | 771 | 921 | 948 | 883 | 939 | 916 | 733 | 520 | 494 | 442 | 357 | 358 | 352 | 387 | 382 | 394 | 397 | 441 |
Current Assets | -6.7% | 387 | 415 | 445 | 506 | 649 | 676 | 660 | 718 | 692 | 508 | 313 | 285 | 270 | 183 | 182 | 175 | 191 | 183 | 190 | 187 | 186 |
Cash Equivalents | -69.3% | 5.00 | 17.00 | 14.00 | 1.00 | 0.00 | 4.00 | 30.00 | 0.00 | 1.00 | 1.00 | 1.00 | 18.00 | 13.00 | 2.00 | 3.00 | 6.00 | 13.00 | 1.00 | 9.00 | 25.00 | 18.00 |
Net PPE | 3.1% | 28.00 | 27.00 | 26.00 | 25.00 | 23.00 | 20.00 | 19.00 | 18.00 | 17.00 | 16.00 | 15.00 | 14.00 | 13.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 12.00 | 13.00 | 14.00 |
Goodwill | 0.0% | 135 | 135 | 135 | 137 | - | 163 | 20.00 | 113 | 119 | 0.00 | 113 | 128 | 91.00 | 91.00 | 91.00 | 91.00 | 101 | 101 | 101 | 101 | 101 |
Liabilities | -12.5% | 180 | 206 | 238 | 301 | 469 | 491 | 460 | 528 | 560 | 435 | 304 | 302 | 269 | 202 | 209 | 203 | 226 | 219 | 230 | 232 | 225 |
Current Liabilities | -13.6% | 128 | 149 | 184 | 216 | 265 | 272 | 277 | 269 | 283 | 200 | 145 | 122 | 122 | 93.00 | 97.00 | 99.00 | 99.00 | 85.00 | 93.00 | 94.00 | 90.00 |
Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 71.00 | 71.00 | 71.00 | 75.00 |
LT Debt, Current | - | - | - | - | - | - | - | - | - | 2.00 | 4.00 | 3.00 | 3.00 | - | 2.00 | - | - | - | - | - | - | - |
LT Debt, Non Current | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 71.00 | 71.00 | 71.00 | 75.00 |
Shareholder's Equity | -1.1% | 468 | 473 | 470 | 470 | 452 | 457 | 423 | 411 | 356 | 298 | 217 | 192 | 174 | 155 | 149 | 149 | 161 | 164 | 164 | 165 | 216 |
Retained Earnings | 1.1% | 241 | 238 | 229 | 217 | 195 | 166 | 127 | 92.00 | 39.00 | -22.73 | -100 | -123 | -135 | -154 | -159 | -158 | -143 | -141 | -140 | -137 | -85.83 |
Additional Paid-In Capital | -3.3% | 229 | 236 | 242 | 255 | 258 | 293 | 297 | 320 | 318 | 322 | 318 | 317 | 310 | 310 | 309 | 308 | 306 | 306 | 305 | 304 | 303 |
Accumulated Depreciation | 8.4% | 17.00 | 16.00 | 20.00 | 20.00 | 19.00 | 18.00 | 20.00 | 19.00 | 18.00 | 18.00 | 18.00 | 18.00 | 18.00 | 17.00 | 22.00 | 21.00 | 24.00 | 23.00 | 35.00 | 36.00 | 35.00 |
Shares Outstanding | -0.2% | 34.00 | 34.00 | 35.00 | 35.00 | 36.00 | 36.00 | 37.00 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Minority Interest | - | - | - | - | - | - | - | - | - | - | - | - | 1.00 | 1.00 | 1.00 | 1.00 | 0.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
Float | - | - | - | - | 927 | - | - | - | 730 | - | - | - | 597 | - | - | - | 218 | - | - | - | 331 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | -50.2% | 6,011 | 12,074 | 70,311 | 119,248 | 46,865 | 4,320 | 140,627 | 18,141 | -29,038 | -73,365 | -2,831 | 15,505 | -24,927 | 1,929 | -8,456 | 16,569 | 17,162 | -5,351 | -14,249 | 12,355 | 12,787 |
Share Based Compensation | 2.7% | 1,198 | 1,166 | 1,433 | 2,205 | 1,775 | 2,187 | 1,491 | 2,114 | 1,601 | 1,637 | 1,771 | 2,137 | 1,349 | 1,340 | 1,064 | 2,072 | 927 | 879 | 982 | 1,004 | 531 |
Cashflow From Investing | 23.1% | -2,210 | -2,875 | -3,408 | -3,996 | -3,496 | -37,111 | -2,915 | -1,752 | -2,096 | -4,686 | -1,888 | -26,286 | -1,186 | -956 | -1,169 | -1,528 | -962 | -898 | -368 | -429 | -1,245 |
Cashflow From Financing | -144.0% | -15,653 | -6,416 | -53,273 | -114,871 | -46,681 | 6,075 | -107,661 | -17,321 | 31,308 | 78,225 | -12,569 | 15,434 | 38,004 | -2,827 | 6,818 | -21,402 | -4,599 | -2,186 | -735 | -5,383 | -9,295 |
Buy Backs | -0.5% | 6,368 | 6,403 | 14,768 | 4,723 | 31,760 | 10,937 | 24,348 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
Revenue from Contract with Customer, Product and Service [Extensible List] | Service [Member] | Service [Member] |
Revenue from services | $ 379,174 | $ 622,707 |
Operating expenses: | ||
Direct operating expenses | 301,877 | 483,284 |
Selling, general and administrative expenses | 63,252 | 84,260 |
Bad debt expense | 1,290 | 4,908 |
Depreciation and amortization | 4,642 | 4,904 |
Restructuring costs | 938 | 429 |
Legal and other losses | 3,650 | 1,125 |
Impairment charges | 604 | 0 |
Total operating expenses | 376,253 | 578,910 |
Income from operations | 2,921 | 43,797 |
Other expenses (income): | ||
Interest expense | 462 | 3,690 |
Other income, net | (1,230) | (12) |
Income before income taxes | 3,689 | 40,119 |
Income tax expense | 997 | 10,683 |
Net income attributable to common stockholders | 2,692 | 29,436 |
Other comprehensive (loss) income: | ||
Unrealized foreign currency translation (loss) gain, net of tax | (3) | 7 |
Comprehensive income | $ 2,689 | $ 29,443 |
Net income per share attributable to common stockholders - Basic (in dollars per share) | $ 0.08 | $ 0.82 |
Net income per share attributable to common stockholders - Diluted (in dollars per share) | $ 0.08 | $ 0.81 |
Weighted average common shares outstanding: | ||
Basic (shares) | 34,216 | 35,864 |
Diluted (shares) | 34,597 | 36,560 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 5,242 | $ 17,094 |
Accounts receivable, net of allowances of $20,145 in 2024 and $20,547 in 2023 | 357,458 | 372,352 |
Income taxes receivable | 6,326 | 6,898 |
Prepaid expenses | 7,616 | 7,681 |
Insurance recovery receivable | 8,815 | 9,097 |
Other current assets | 1,861 | 2,031 |
Total current assets | 387,318 | 415,153 |
Property and equipment, net of accumulated depreciation of $17,135 in 2024 and $15,808 in 2023 | 28,200 | 27,339 |
Operating lease right-of-use assets | 1,831 | 2,599 |
Goodwill | 135,430 | 135,430 |
Other intangible assets, net | 51,742 | 54,468 |
Deferred tax assets | 6,805 | 5,954 |
Insurance recovery receivable | 23,120 | 25,714 |
Cloud computing | 7,209 | 5,987 |
Other assets | 6,784 | 6,673 |
Total assets | 648,439 | 679,317 |
Current liabilities: | ||
Accounts payable and accrued expenses | 68,921 | 85,333 |
Accrued compensation and benefits | 51,606 | 52,297 |
Operating lease liabilities | 2,362 | 2,604 |
Earnout liability | 4,100 | 6,794 |
Other current liabilities | 1,453 | 1,559 |
Total current liabilities | 128,442 | 148,587 |
Operating lease liabilities | 2,130 | 2,663 |
Accrued claims | 34,299 | 34,853 |
Earnout liability | 0 | 5,000 |
Uncertain tax positions | 11,339 | 10,603 |
Other liabilities | 4,039 | 4,218 |
Total liabilities | 180,249 | 205,924 |
Commitments and contingencies | ||
Stockholders’ equity: | ||
Common stock | 4 | 4 |
Additional paid-in capital | 228,525 | 236,417 |
Accumulated other comprehensive loss | (1,388) | (1,385) |
Retained earnings | 241,049 | 238,357 |
Total stockholders’ equity | 468,190 | 473,393 |
Total liabilities and stockholders’ equity | $ 648,439 | $ 679,317 |